Oric Pharmaceuticals Inc (ORIC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ORIC Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Oric Pharmaceuticals Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent37.48
Available-for-sale Securities, Debt Securities, Current MA227.28
Cash & Short-term Investments264.00
Prepaid Expense And Other Assets Current8.93
Total Current Assets273.70
Equipment/Property/Plant Net10.43
Long-term investments123.29
Other Assets, Noncurrent0.00
Total Assets404.69
Liabilities
Accounts Payable, Current AC3.87
Accrued Liabilities, Current AC16.88
Total Current Liabilities20.76
Total Long-term Debt0.00
Other liabilities, Noncurrent2.67
Total Liabilities23.43
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock1,151.76
Retained Earnings / Accumulated Deficit-769.50
Accumulated Other Comprehensive Income-1.02
Other Equity-1.02
Common Stockholder's Equity381.26
Total Stockholder's Equity381.26
Liabilities & Stockholder's Equity404.69
4 historic quarters locked

Sign in to unlock the full Oric Pharmaceuticals Inc balance sheet history.

About Oric Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-330631

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.